Greenwich LifeSciences, Inc. (GLSI)
Pharmaceutical Preparations
Latest Price
$13.50
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.36
P/B Ratio
37.31
Institutional Ownership
11.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 433.9K | $10.0M | 2.96% | +62.4K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 298.3K | $7.0M | 2.03% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 155.5K | $3.0M | 1.06% | +3.8K | 2026-03-31 |
| STATE STREET CORP | 133.9K | $3.0M | 0.91% | +36.1K | 2026-03-31 |
| Nuveen, LLC | 88.7K | $2.0M | 0.60% | -- | 2026-03-31 |
| NORTHERN TRUST CORP | 75.1K | $1.0M | 0.51% | +2.1K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 58.9K | $1.0M | 0.40% | -- | 2026-03-31 |
| Bank of New York Mellon Corp | 46.5K | $1.0M | 0.32% | +32.7K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 44.9K | $1.0M | 0.31% | -- | 2026-03-31 |
| Russell Investments Group, Ltd. | 39.7K | -- | 0.27% | +39.1K | 2026-03-31 |